Top Healthcare Stocks
JNJ -0.3% from near 52 week highs regular hours, -0.1% after
Healthcare stocks were mixed with the NYSE Healthcare Sector
Index rising 0.5% while shares of healthcare companies in the
S&P 500 were down 0.2% as a group.
In company news, Intellipharmaceutics (
) recovered early losses that saw it open at $3.55 and touch $3.52
but rally through the close and end up 2 cents at a day high $3.94
a share after late Wednesday announcing plans to sell up to 5.3
million shares of its common stock through an "at-the-market"
offering program from time to time.
The maker of controlled and targeted-releasse solid dosage drug
said it is seeking up to $16.8 million in proceeds from the
periodic stock sales. IPCI does not have any specific plans for the
new funds other than for working capital, although it will use
about $800,000 to repay a related-party loan.
In other sector news,
(+) MDXG, (+5.9%) Receives an extension for the pass-through
reimbursement status of its EpiFix allograft product through
(-) THO, (-0.6%) Studies by the Cleveland Clinic and other
facilities released late Wednesday find patients who had the
company's HeartMate II heart-assist pump implanted after March 2011
had nearly four times the risk of potentially fatal blood clots
than patients getting the device before that time.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.